Cytek Biosciences, Inc.

Annual Trend FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $165.2m $364.6m $296.6m $167.3m $98.7m $90.9m
Prepaid Expense and Other Assets, Current $2.5m $5.2m $13.0m $12.5m $14.1m $19.5m
Inventory, Net $23.0m $32.2m $48.2m $60.9m $43.9m $48.4m
Assets, Current $208.6m $431.7m $454.0m $392.1m $396.4m $392.0m
Property, Plant and Equipment, Net $2.1m $5.9m $13.7m $18.4m $18.0m $18.0m
Goodwill $476k $10.1m $10.1m $16.2m $16.7m $16.7m
Intangible Assets, Net (Excluding Goodwill) $274k $4.7m $4.3m $23.1m $20.1m $16.8m
Operating Lease, Right-of-Use Asset $0 $13.9m $10.9m $10.2m $11.3m
Other Assets, Noncurrent $1.1m $1.7m $3.0m $3.4m $4.8m $6.7m
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $17.0m $29.8m $48.9m $55.9m $60.6m $62.5m
Accrued Liabilities, Current $9.0m $15.3m $21.1m $20.0m $21.4m $23.4m
Assets $220.0m $463.3m $519.5m $494.5m $499.5m $461.5m
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $0 $2.9m $2.4m $3.8m $2.9m
Operating Lease, Liability, Noncurrent $0 $12.3m $9.5m $7.6m $14.0m
Deferred Revenue, Current $3.7m $7.1m $13.0m $22.7m $25.5m $28.5m
Deferred Revenue, Noncurrent $3.5m $9.8m $13.1m $15.1m $16.1m $18.3m
Liabilities, Current $26.5m $33.2m $49.0m $56.2m $67.7m $77.8m
Other Liabilities, Noncurrent $737k $1.2m $1.6m $2.4m $2.4m $2.3m
Deferred Tax Liabilities, Net $404k $777k $4.0m $3.2m $2.6m $182k
Liabilities $41.7m $57.9m $93.9m $101.4m $103.8m $119.8m
Stockholders’ equity:
Common Stock, Value, Issued $23k $126k $135k $131k $129k $129k
Additional Paid in Capital $6.5m $423.6m $442.9m $423.4m $430.8m $441.1m
Retained Earnings (Accumulated Deficit) ($22.6m) ($19.6m) ($17.0m) ($29.2m) ($35.2m) ($101.7m)
Accumulated Other Comprehensive Income (Loss), Net of Tax $65k $897k ($697k) ($1.3m) $16k $2.2m
Stockholders' Equity Attributable to Parent ($16.0m) $405.4m $425.5m $393.1m $395.7m $341.7m
Liabilities and Equity $220.0m $463.3m $519.5m $494.5m $499.5m $461.5m